Maximilian Mastall

5PUBLICATIONS
14CO-AUTHORS
Gene and molecular therapyCentral nervous systemMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 08, 2026
A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of meningioma.

|Jul 14, 2026
Spinal high-grade astrocytoma with piloid features presenting with progressive encephalopathy, hypoglycorrhachia, hydrocephalus, and leptomeningeal dissemination.

|Feb 10, 2026
Targeted next-generation sequencing-based sequencing of cell-free DNA in cerebrospinal fluid uncovers cancer-specific mutations in patients with brain cancer using a widely available panel.

Alexander Köpp, Peter Westarp, Marta Nowak

|Jun 19, 2023
Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.

Lena Hänsch, Matthias Peipp, Maximilian Mastall

|May 11, 2021
Survival of brain tumour patients with epilepsy.

Maximilian Mastall, Fabian Wolpert, Dorothee Gramatzki

Pageof 1

Frequent Collaborators

5 joint publications

Michael Weller

2 joint publications

Hans-Georg Wirsching

2 joint publications

Flavio Vasella

2 joint publications

Patrick Roth